Pharmacological fMRI: A New Tool for Drug Development in Humans

Tracey, Irene and Wise, Richard Geoffrey ORCID: https://orcid.org/0000-0003-1700-2144 2001. Pharmacological fMRI: A New Tool for Drug Development in Humans. Journal of Pharmacy Practice 14 (5) , pp. 368-375. 10.1106/QACM-FBX4-90UK-FRW6

Full text not available from this repository.

Abstract

Until now, our understanding of human brain pharmacology has depended on indirect assessments or animal models. The advent of pharmacological functional magnetic resonance imaging (phMRI) has enabled researchers to focus directly on human pharmacology and brain function. Functional MRI, with its increased spatial and temporal resolution, has a further advantage over other neuroimaging methods in that being totally noninvasive, it allows serial, longitudinal studies to be performed on the same subject. This opens the door to a new era of phMRI, as the effects of drugs can be readily monitored in one subject (control or patient) over time. In addition, sophisticated paradigms can be developed that can isolate specific brain regions of activation. These regions can then be subsequently targeted and challenged with appropriate drugs. This allows for a “battery” of paradigms aimed at determining a drug’s mechanism and site of action, which would be valuable for drug development and discovery.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Psychology Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	B Philosophy. Psychology. Religion > BF Psychology R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords:	phMRI; fMRI; pharmacology; neuroimaging; brain; magnetic resonance imaging
Publisher:	SAGE Publications
ISSN:	0897-1900
Last Modified:	20 Oct 2022 09:55
URI:	https://orca.cardiff.ac.uk/id/eprint/33524

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item